SS

Sanjay Singhal

Active Director Director DIN 01821348
DIN 01821348 First appointment Jul 2005 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Singhal

Data last updated:

Sanjay Singhal is a Director at Zen Biotech Private Limited (since 2005). The company operates in Pharma.

DIN 01821348
Primary Designation Director
Industry Pharma
First Appointment 21 Jul 2005
Oldest Company Age 21 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zen Biotech Private Limited U24232UR2005PTC030404
Director21 Jul 20052005Active

Board colleagues of Sanjay Singhal

Directorship timeline

Open interactive timeline →
Zen Biotech Private Limited
Premium access

Shareholding and investment profile for Sanjay Singhal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Singhal

Sanjay Singhal currently holds 1 directorship: Zen Biotech Private Limited (Director, since 21 Jul 2005).

Sanjay Singhal was first appointed on 21 Jul 2005 as Director at Zen Biotech Private Limited.

The current boards of Sanjay Singhal's companies include Deepak Singhal (Zen Biotech Private Limited), Saurabh Kumar Goel (Zen Biotech Private Limited), Sharad Singhal (Zen Biotech Private Limited), Tarun Kumar Goel (Zen Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available